Management of Patients with Sore Throat and Negative Rapid Strep Tests

Clinical Assessment

The Centor clinical scoring system can help identify patients with higher likelihood of group A streptococcal infection, considering factors such as fever, absence of cough, tonsillar exudates, and tender anterior cervical lymphadenopathy 1
Patients with only sore throat without other symptoms suggest a lower Centor score (likely 0-2), which indicates low probability of streptococcal infection 3
Despite the exposure history to strep-positive individuals, the negative rapid strep test results are reliable enough to guide management 2

If rapid antigen detection tests (RADTs) are performed, throat culture is not necessary after a negative RADT for the diagnosis of group A streptococci in both children and adults 1
The specificity of most RADTs is excellent (≥95%) compared with blood agar plate culture, meaning false-positive results are unusual 4
The sensitivity of most RADTs is between 80-90%, and the negative predictive value is high enough that confirmation with throat culture is not always necessary, especially in adults with low clinical suspicion 5, 4

Antibiotics should not be used in patients with less severe presentation of sore throat (0-2 Centor criteria) to relieve symptoms 1
For symptomatic relief, either ibuprofen or paracetamol (acetaminophen) is recommended 1
Sore throat should not be treated with antibiotics to prevent complications in low-risk patients with no previous history of rheumatic fever 1
The modest benefits of antibiotics have to be weighed against side effects, impact on microbiota, increased antimicrobial resistance, and costs 2

Despite the exposure to strep-positive individuals, the negative rapid tests and minimal symptoms (only sore throat) do not warrant antibiotic therapy 1, 6

Assuming that exposure history alone warrants treatment despite negative testing and minimal symptoms 1, 2
Failing to provide adequate symptomatic relief, which is the mainstay of treatment for viral pharyngitis 1
Requesting unnecessary additional testing (such as throat cultures or biomarkers) when rapid tests are negative in low-risk patients 1, 3